Company Dossiers

BillionToOne, Inc. (NASDAQ: BLLN) is a next-generation molecular diagnostics company specializing in ultra-sensitive genetic testing. The company's proprietary Quantitative Counting Templates (QCT) molecular counting platform enables the detection and precise…

Bimergen Energy Corp (formerly Bitech Technologies Corporation) is a Newport Beach, California-based independent power provider and renewable energy project developer. The company specializes in the development, ownership, and operation of utility-scale stand…

Binah Capital Group, Inc. (NASDAQ: BCG) is a wealth management holding company and broker-dealer aggregator that operates a national platform supporting independent financial advisors and hybrid Registered Investment Advisors (RIAs). Formed through the merger…

BingEx Ltd (operating under the commercial brand FlashEx or Shan Song) is the pioneer and largest independent on-demand dedicated courier service provider in China. Founded in May 2014 and headquartered in Beijing, the company operates a unique one-to-one ded…

Bio Green Med Solution, Inc. (formerly Cyclacel Pharmaceuticals, Inc.) is a diversified company that has strategically pivoted from its clinical-stage biopharmaceutical roots to focus primarily on fire safety protection and distribution activities. Headquarte…

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostics markets. Headquartered in Hercules, California, the com…

Bio-Techne Corporation (NASDAQ: TECH) is a leading global life sciences company that develops, manufactures, and sells high-quality biotechnology reagents, analytical instruments, and precision diagnostics. Celebrating 50 years of empowering the scientific an…

bioAffinity Technologies, Inc. (Nasdaq: BIAF) is a biotechnology company focused on addressing the critical need for noninvasive, accurate diagnostic tests and targeted therapeutics for early-stage lung cancer and other lung diseases. The company's core comme…

BioAge Labs, Inc. (NASDAQ: BIOA) is a clinical-stage biopharmaceutical company dedicated to developing therapeutic product candidates for metabolic and cardiometabolic diseases, such as obesity, by targeting the biology of human aging. Founded in 2015, the co…

BioAtla, Inc. (NASDAQ: BCAB) is a clinical-stage biopharmaceutical company headquartered in San Diego, California, specializing in the development of a novel class of highly specific and selective antibody-based therapeutics for solid tumor cancers. The compa…

BioCardia, Inc. (NASDAQ: BCDA) is a clinical-stage regenerative medicine company focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. The company's therapeutic platforms include autologous an…

BioHarvest Sciences Inc. (NASDAQ: BHST; FSE: 8MV0) is a global leader in Botanical Synthesis and plant cell biology. The company utilizes its patented Bio-Plant CELLicitation™ technology platform to grow active plant-based compounds in industrial-scale biorea…

BioNTech SE is a Germany-based next-generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The company exploits a wide array of computational discovery and therapeutic drug platforms to rapidly develop novel biophar…

BioNexus Gene Lab Corp. (NASDAQ: BGLC) is a precision diagnostics and specialty chemical solutions company headquartered in Kuala Lumpur, Malaysia. The company operates through two primary subsidiaries: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scienti…

BioRestorative Therapies, Inc. (NASDAQ: BRTX) is a clinical-stage regenerative medicine company focused on developing therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The company's primary clini…

BioVie Inc. (NASDAQ: BIVI) is a clinical-stage biopharmaceutical company focused on developing innovative drug therapies to treat chronic, debilitating conditions. The company's pipeline targets two primary therapeutic areas: neurodegenerative disorders (incl…

BioXcel Therapeutics, Inc. (Nasdaq: BTAI) is a clinical-stage biopharmaceutical company utilizing artificial intelligence (AI) to develop transformative medicines in neuroscience. The company's proprietary drug re-innovation approach leverages big data and ma…

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a global leader in the development and commercialization of agricultural biotechnology and biological solutions designed to regenerate ecosystems and enhance crop resilience to climate change. Headquartered in R…

BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company focused on discovering, developing, and commercializing novel, orally administered, small-molecule therapeutics for rare and orphan diseases. The company's primary commercial driver is…

Biodesix, Inc. (Nasdaq: BDSX) is a leading diagnostic solutions company specializing in personalized medicine for lung diseases. The company develops and commercializes blood-based diagnostic tests that assist physicians in early lung cancer detection, risk a…